Skip to main content
Fig. 3 | Journal for ImmunoTherapy of Cancer

Fig. 3

From: The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors

Fig. 3

Response to treatment according to intratumoral and peritumoral density CD8+ T cells and CD163+ macrophages. Low: score = 0, 1+; High: score = 2+,3+; non responder: patients who have experienced a stable or progressive disease as best response to therapy; responder: patients who have experienced a complete or partial response as best response to therapy

Back to article page